A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

NCT00614471 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

219

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Entecavir
DRUG: Entecavir
DRUG: peginterferon alfa-2a [Pegasys]
DRUG: peginterferon alfa-2a [Pegasys]

Sponsor

Hoffmann-La Roche